AP2B1 and Alzheimer disease: AP-2 complex subunit beta, the syntaxins, Rab GDI alpha, and PEBP-1 are all implicated in the process of synapse vesicle exocytosis and neurotransmitter release at the synaptic cleft, and their CSF levels have previously been shown to be abnormal in AD [14, 33–36].